Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array
of immunomodulatory treatment options compared with IPF, due to their inflammatory …

A proportion of patients with interstitial lung diseases (ILDs), including the ILDs that are
commonly associated with autoimmune diseases, develop a progressive fibrosing …

BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) or Usual Interstitial Pneumonia (UIP) is
a form of chronic fibrosing interstitial pneumonia of unknown aetiology, with progressively …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of
connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and …

Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases
and a leading cause of death in these patients. A proportion of patients with autoimmune …

Interstitial lung diseases (ILD) represent a group of heterogeneous parenchymal lung
disorders with complex pathophysiology, characterized by different clinical and radiological …

Background Standard of care for interstitial lung disease (ILD) with a nonspecific interstitial
pneumonia (NSIP) pattern proposes mycophenolate mofetil (MMF) as one of the first-step …

Inflammatory myopathies are heterogeneous clinico-serological syndromes, with variable
clinical manifestations. Interstitial lung disease (ILD) is a major cause of morbidity and …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications associated
with connective tissue diseases (CTDs), resulting in significant morbidity and mortality …

The role of immunity in the pathogenesis of various pulmonary diseases, particularly
interstitial lung diseases (ILDs), is being increasingly appreciated as mechanistic …